04:51 PM EST, 02/18/2025 (MT Newswires) -- Yvonne Greenstreet, Director, Chief Executive Officer, on February 13, 2025, sold 1,213 shares in Alnylam Pharmaceuticals ( ALNY ) for $309,527. Following the Form 4 filing with the SEC, Greenstreet has control over a total of 81,933 common shares of the company, with 81,526 shares held directly and 407 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1178670/000173527625000012/xslF345X05/edgardoc.xml